Similar Articles
721 Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
722 Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
723 Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
724 Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
725 Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study
726 Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
727 Intracuff alkalinized lidocaine to prevent postoperative airway complications: A meta-analysis
728 Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis
729 Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
730 Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA